CXCL10 and neoplasm: In esophageal cancer, IDO1 promotes tumor progression by facilitating the nuclear translocation of NF-κB and its binding to the CXCL10 promoter, thereby regulating the expression of the chemokine C-X-C motif ligand 10 (CXCL10) (92).